Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Arcus Biosciences, Inc.

RCUS · NYSE · CIK 0001724521 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

19 Form 4 transaction lines observed in the same window
10 sales · 9 option, withholding, award, gift or other lines

Last qualifying purchase2025-02-27 · KANEKO YASUNORI · $201.2K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Jaen Juan C.President
▼▼▼▼▼
Azoy AlexanderChief Accounting Officer
▼○▼
Machado PatrickDirector
○
Lambert NicoleDirector
○
KANEKO YASUNORIDirector
○
Tang Carolyn C.General Counsel
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 5 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-02-27 · KANEKO YASUNORI.

Recent Form 4 activity

0Purchases
42Sales
20Other Form 4 lines
39SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING10 sale line(s) · context only
OTHER9 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
13,110,576
Previous report
13,812,606
Avg daily volume
1,716,447
Days to cover
7.6

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-02-27ROSEN TERRY JPurchase (P)Common Stock19,800USD 10.18USD 201,564SEC filing ↗
2025-02-27KANEKO YASUNORIPurchase (P)Common Stock20,000USD 10.06USD 201,200SEC filing ↗
2025-02-18GILEAD SCIENCES, INC.Purchase (P)Common Stock1,363,636USD 11.00USD 14,999,996SEC filing ↗
2024-01-29GILEAD SCIENCES, INC.Purchase (P)Common Stock15,238,095USD 21.00USD 319,999,995SEC filing ↗
2023-06-28GILEAD SCIENCES, INC.Purchase (P)Common Stock1,010,000USD 19.26USD 19,452,600SEC filing ↗
2021-04-23KANEKO YASUNORIPurchase (P)Common Stock4,133USD 31.37USD 129,652SEC filing ↗
2021-03-31FALBERG KATHRYN EPurchase (P)Common Stock20,000USD 28.35USD 567,000SEC filing ↗
2021-01-31GILEAD SCIENCES INCPurchase (P)Common Stock5,650,000USD 39.00USD 220,350,000SEC filing ↗
2020-09-09Goeltz II Robert C.Purchase (P)Common Stock5,000USD 21.57USD 107,850SEC filing ↗
2020-08-10ROSEN TERRY JPurchase (P)Common Stock32,050USD 23.38USD 749,329SEC filing ↗
2020-08-07ROSEN TERRY JPurchase (P)Common Stock11,655USD 21.44USD 249,883SEC filing ↗
2020-07-31Grossman WilliamPurchase (P)Common Stock200USD 19.73USD 3,945SEC filing ↗

Form 4 evidence

62 transaction lines in the latest 365-day window; 307 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-21Azoy AlexanderSale (S)Common Stock2,827USD 30.00USD 84,810SEC filing ↗
2026-08-21Azoy AlexanderOption exercise / conversion (M)Common Stock2,827USD 15.44USD 43,649SEC filing ↗
2026-07-10Jaen Juan C.Sale (S)Common Stock20,067USD 28.62USD 574,329SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-21Azoy AlexanderSale (S)Common Stock2,827USD 30.00USD 84,810SEC filing ↗
2026-08-21Azoy AlexanderOption exercise / conversion (M)Common Stock2,827USD 15.44USD 43,649SEC filing ↗
2026-07-10Jaen Juan C.Sale (S)Common Stock20,067USD 28.62USD 574,329SEC filing ↗
2026-07-09Jaen Juan C.Sale (S)Common Stock48,502USD 30.05USD 1,457,485SEC filing ↗
2026-06-24Jaen Juan C.Sale (S)Common Stock6,431USD 29.66USD 190,743SEC filing ↗
2026-06-23Jaen Juan C.Sale (S)Common Stock15,764USD 27.73USD 437,133SEC filing ↗
2026-06-22Jaen Juan C.Sale (S)Common Stock9,236USD 27.03USD 249,649SEC filing ↗
2026-06-11Tang Carolyn C.Option exercise / conversion (M)Common Stock34,090USD 2.57USD 87,611SEC filing ↗
2026-06-11Ribas AntoniAward / grant (A)Common Stock5,700USD 0.00USD 0SEC filing ↗
2026-06-11PERLMAN ANDREW JAward / grant (A)Common Stock5,700USD 0.00USD 0SEC filing ↗
2026-06-11Machado PatrickAward / grant (A)Common Stock5,700USD 0.00USD 0SEC filing ↗
2026-06-11Lambert NicoleAward / grant (A)Common Stock5,700USD 0.00USD 0SEC filing ↗
2026-06-11Lacey David L.Award / grant (A)Common Stock5,700USD 0.00USD 0SEC filing ↗
2026-06-11KANEKO YASUNORIAward / grant (A)Common Stock5,700USD 0.00USD 0SEC filing ↗
2026-06-11FALBERG KATHRYN EAward / grant (A)Common Stock5,700USD 0.00USD 0SEC filing ↗
2026-06-01Azoy AlexanderSale (S)Common Stock2,562USD 25.77USD 66,023SEC filing ↗
2026-05-11Goeltz II Robert C.Sale (S)Common Stock7,763USD 25.63USD 198,966SEC filing ↗
2026-01-23Tang Carolyn C.Award / grant (A)Common Stock24,000USD 0.00USD 0SEC filing ↗
2026-01-23ROSEN TERRY JAward / grant (A)Common Stock79,000USD 0.00USD 0SEC filing ↗
2026-01-23Markus RichardAward / grant (A)Common Stock24,000USD 0.00USD 0SEC filing ↗
2026-01-23Jarrett JenniferAward / grant (A)Common Stock31,000USD 0.00USD 0SEC filing ↗
2026-01-23Jaen Juan C.Award / grant (A)Common Stock31,000USD 0.00USD 0SEC filing ↗
2026-01-23Goeltz II Robert C.Award / grant (A)Common Stock24,000USD 0.00USD 0SEC filing ↗
2026-01-23Azoy AlexanderAward / grant (A)Common Stock21,050USD 0.00USD 0SEC filing ↗
2026-01-08ROSEN TERRY JGift (G)Common Stock35,000USD 0.00USD 0SEC filing ↗
2026-01-05Jaen Juan C.Sale (S)Common Stock31,823USD 21.41USD 681,342SEC filing ↗
2025-12-31Goeltz II Robert C.Sale (S)Common Stock6,552USD 23.38USD 153,186SEC filing ↗
2025-12-30ROSEN TERRY JGift (G)Common Stock2,400USD 0.00USD 0SEC filing ↗
2025-12-18Azoy AlexanderSale (S)Common Stock4,343USD 22.25USD 96,632SEC filing ↗
2025-12-17Tang Carolyn C.Sale (S)Common Stock6,810USD 22.16USD 150,910SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerRCUS
CIK0001724521
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNYSE

Data coverage

Local Form 4 history307 transaction lines from 2020-06-04 to 2026-08-21
13 P purchase lines · 151 S sale lines · 143 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.